ZHANG Shuyao,HOU Tieying,LI Xiaoyan,ZHONG Shilong,WU Junyan,HUANG Bin,Division of Therapeutic Drug Monitoring of Chinese Pharmacological Society,Expert Committee of Precision Medicine for Clinical Treatment of Guangdong Pharmaceutical Association,the Writing Group of the Expert Consensuses on the Application of Nanopore Sequencing Technology in the Detection of Pathogenic Microorganisms
摘要:OBJECTIVETo improve the diagnosis and treatment level of critically ill infectious diseases, standardize the clinical application of nanopore sequencing and promote the sound development of the technology.METHODSDivision of Therapeutic Drug Monitoring of Chinese Pharmacological Society and Expert Committee of Precision Medicine for Clinical Treatment of Guangdong Pharmaceutical Association initiated and organized multidisciplinary experts to discuss and determine the consensus writing outline by using the nominal group method, forming a preliminary consensus draft; expert consultation was performed by using Delphi method, and then experts’ opinions were analyzed and revised to form consensus.RESULTS &CONCLUSIONSConsensuses of Experts on the Application of Nanopore Sequencing Technology in the Detection of Pathogenic Microorganisms covers targeted sequencing, metagenomic sequencing and whole genome sequencing, and is standardized in terms of sample collection and storage, detection process, bioinformatics analysis and report interpretation; the recommendations are provided for the key issues.
摘要:OBJECTIVETo clarify the institutional logics of the dilemma of the use of national medical insurance negotiation drugs(referred to as “national negotiation drugs”), and promote the implementation and use of these drugs in medical institutions.METHODSBased on the complex institutional environment in which medical institutions were situated, the theory of multiple institutional logics was used to construct an analytical framework for the behavioral choices of medical institutions, and reveal the mechanism of the difficulty in the use of national negotiation drugs by clarifying the interaction and conflict of multiple logics in this process, so as to put forward some measures. RESULTS &CONCLUSIONSThere were contradictions and coupling among the state logic, market logic, social logic and professional logic in the use of national negotiation drugs. In the game of multiple logics, the market logic and professional logic tended to be risk-averse, the failed “pressure-type system” of state logic, and the social logic was weakened, which caused the lack of action in the use of national negotiation drugs with the goal of completing performance evaluations in the current medical institutions. Thus, it is suggested to unbundle the invisible policy restrictions on the use of national negotiation drugs, form the pressure and motivation of medical institutions by incentive and constraint mechanisms, respond to the clinical demand by establishing a green procurement channel, and construct the supervision mechanism on the use of national negotiation drugs by social force, etc., so as to enhance the effect of the national negotiation drugs.
摘要:OBJECTIVETo optimize the pre-audit rules for anesthesia prescriptions, improve the audit quality and rational drug use.METHODSThe inpatient medical orders of anesthesia department from prescription pre-audit system of the Affiliated Hospital of Qingdao University (hereinafter referred to as “our hospital”) were analyzed from April 1 to 30, 2023. The classification statistics and evidence-based inquiry were carried out for irrational drug use issues; combined with our hospital’s current implementation of the Anesthesiology Clinical Pathway Medication Standards, the audit rules were set in details, and audit management and communication feedback processes were established. The total number of monthly audited orders, the number of pre-audit pop ups, system interception rate, physician modification rate after system audit, pharmacist audit rate, and reasonable rate of medical orders after refined setting of rules (May-December in 2023) were compared with before setting (April in 2023); the average medication cost per anesthesia session after refined setting of rules was also compared with before setting (May-December in 2022).RESULTSIrrational drug use in the anesthesia department mainly included inappropriate indications, inappropriate administration routes, inappropriate usage and dosage, inappropriate compatibility, medication problems in special populations, and improper medication during the perioperative period. After the refinement of the rules, the number of pre-audit pop ups in the anesthesia department significantly decreased over time, and gradually reached a stable state after continuous improvement. Compared with before setting, the system interception rate after the refinement of rules (P<0.001), physician modification rate after system audit (P<0.001) both increased significantly, while the pharmacist audit rate significantly decreased (P<0.001). There was a linear trend between the reasonable rate of medical orders and the month from May to December in 2023 (P<0.05). Compared with before the setting, the average medication cost of anesthesia per session decreased from 720.72 yuan to 528.21 yuan, with a decrease of 26.71%.CONCLUSIONSBased on evidence-based reference, refining pre-audit rules for anesthesia prescriptions can significantly improve the quality of prescription examination, promote rational drug use, and save patient’s medical expenses.
关键词:anesthesia department;evidence-based reference;audit rules;rational drug use
摘要:OBJECTIVETo provide reference for improving the level of hospital pharmaceutical management for operating room drugs.METHODSThe operating room pharmacy of our hospital utilized the concept and means of the Internet of Things (IoT) to build an intelligent IoT system for operating room drugs (hereinafter referred to as the “IoT system”), and optimized and improved it. The quality of drug management in the operating room of our hospital during the initial phase of the IoT system (Q1 2022) and after optimization and improvement (Q1 2023) were compared by setting indicators from four aspects: quality, efficiency, cost, and satisfaction.RESULTSAfter more than a year of optimization and improvement, our hospital has built a traceable IoT system for the entire drug process that integrated surgical anesthesia systems and hospital information systems, with the direction of drug circulation in the operating room as the axis, using intelligent drug vehicles as the hardware foundation, and anesthesia doctor’s order information system as the software medium. After the optimization and improvement of the IoT system, the standardized score of anesthesia orders in the operating room increased from (68.5±3.5) points in the initial period to (97.0±2.7) points; the consistency rate between accounts and materials increased from (82.40±8.85)% to (96.50±4.80)%; the time of taking medicine was shortened from (40±8) min to (12±3) min; the frequency of drug withdrawal was reduced from (36.0±6.5) times/day to (15.5±3.0) times/day; the cost of loss drugs was decreased from (1 292.61±305.90) yuan to (594.24±195.05) yuan; the satisfaction was increased from (80.5±6.5) points to (96.0±3.0) points. All indicators were significantly improved with statistically significant differences (P<0.05).CONCLUSIONSThe intelligent IoT system constructed by our hospital effectively ensures the accessibility, timeliness, and safety of intraoperative medication, which is conducive to improving the quality of drug management in the operating room.
关键词:intelligent Internet of Things;closed-loop management;anesthetic orders
摘要:OBJECTIVETo investigate the improvement effects of sinomenine (Sin) on non-alcoholic steatohepatitis (NASH) and its potential mechanism.METHODSMale C57BL/6J mice were randomly divided into standard chow diet (SCD) group, high-fat diet (HFD) group, Sin low-dose group (Sin-L group, 50 mg/kg), and Sin high-dose group (Sin-H group, 100 mg/kg), with 6 mice in each group. The mice of SCD groups were fed with SCD, and other groups were given HFD for consecutive 24 weeks to establish NASH model. Since 17th week, the mice in each drug group were given corresponding drug solutions intragastrically, once a day, for 8 consecutive weeks. After the last medication, the body weight and liver weight of mice were determined, and liver indexes were calculated. The contents of total cholesterol (TC) and triglyceride (TG) in liver tissue, the serum contents of aspartate aminotransferase (AST), alanine aminotransferase (ALT), interleukin-1β (IL-1β) and IL-18 were all determined. Hepatic steatosis and fibrosis were observed, and hepatic lipid droplets were located. The expressions of IL-18 and IL-1β mRNA, inflammation-related proteins (IL-1β, cleaved-IL-1β), fibrosis-related proteins [collagen Ⅰ (Col-Ⅰ), α-smooth muscle actin (α-SMA), connective tissue growth factor (CTGF)], and pathway-related protein [adenosine monophosphate-activated protein kinase (AMPK), phosphorylated AMPK (p-AMPK), Yes-associated protein (YAP), phosphorylated YAP (p-YAP)] were all determined. HepG2 human liver cancer cells were selected as subjects and divided into control group, oleic acid (OA) group, Sin 50 μmol/L group, Sin 100 μmol/L group, OA+Sin 50 μmol/L group and OA+Sin 100 μmol/L group. After 24 hours of treatment, the accumulation of lipid droplets was observed, and the expressions of pathway-related proteins were detected.RESULTSCompared to HFD group, hepatic steatosis, fibrotic lesions and lipid droplet accumulation were all alleviated in Sin groups; body weight, liver weight, liver indexes, the contents of AST, ALT, IL-1β, IL-18 in serum and TG, TC in liver tissue, the mRNA expressions of IL-1β and IL-18, and the expressions of cleaved-IL-1β and fibrosis-related proteins all decreased significantly (P<0.01); the protein expression of IL-1β, and the phosphorylation levels of AMPK and YAP proteins significantly increased (P<0.01). Compared with OA group, the lipid droplet accumulation of cells in OA+Sin groups significantly decreased, while the phosphorylation levels of AMPK and YAP proteins significantly increased (P<0.05).CONCLUSIONSSin can ameliorate the inflammation, lipid deposition and fibrosis of liver tissue in mice, the mechanism of which may be associated with activating the AMPK signaling pathway and promoting YAP phosphorylation.
摘要:OBJECTIVETo evaluate the palatability and chewability of chewable tablets, and provide reference for the quality evaluation of various types of chewable tablets.METHODSUsing self-made Glucosamine hydrochloride chewable tablets as the model drug, the quality test was conducted. The in vitro simulation system for chewable tablets was established by using a texture analyzer and rheometer, and an oral simulation experiment was conducted on chewable tablets. The texture analyzer was used to measure the force required for chewing and simulate the static disintegration process of chewable tablets; the rheometer was adopted to measure the viscoelasticity, thixotropy, and deformability of chewable tablets during the chewing process.RESULTSThe disintegration time limit, principal component content, and dissolution of self-made Glucosamine hydrochloride chewable tablets all met the limit requirements. The in vitro simulation results of the texture analyzer showed that self-made chewable tablets were easy to chew in both axial and radial directions, and the force required for chewing was within the range of the chewing force of the teeth; chewable tablets could disintegrate at an appropriate time without being chewed and only taken in the oral cavity. The in vitro simulation results of the rheometer showed that the chewable tablets in the oral cavity exhibited a behavior of elasticity as the main factor and viscosity as the secondary factor through the continuous stirring of the tongue, and the viscosity of the chewable tablets gradually decreased with tongue stirring or tooth chewing; when chewing with teeth, the internal force of the chewing tablets decreased, causing plastic deformation and crushing. After being crushed, the shape couldn’t be restored, making it easy to chew and swallow.CONCLUSIONSThe combination of texture analyzer and rheometer can be used to simulate the oral chewing process and evaluate the palatability and chewability of self-made Glucosamine hydrochloride chewable tablets. This model can provide reference for the evaluation of various chewable tablets.
摘要:OBJECTIVETo identify the chemical constituents of Rhamni Songoricae Fructus and to establish their fingerprints and the method for simultaneous determination of four constituents to comprehensively evaluate the quality of Rhamni Songoricae Fructus.METHODSThe chemical constituents in Rhamni Songoricae Fructus were qualitatively analyzed by ultra-performance liquid chromatography quadrupole-time-of-flight tandem mass spectrometry. The fingerprints of 15 batches of Rhamni Songoricae Fructus were established by HPLC and chemometric analysis was performed by using SPSS 26.0 and SIMCA 14.1 software; the contents of quercetin, kaempferol, kaempferide and emodin were determined by the same method.RESULTSA total of 35 constituents were identified, including 28 kinds of flavonoids, 5 kinds of anthraquinones and 2 kinds of organic acids. A total of 19 common peaks were identified in the HPLC fingerprints, recognizing quercetin, kaempferol, kaempferide and emodin. The similarities between HPLC fingerprints of 15 batches of samples and control chromatograms were greater than 0.9. The results of cluster analysis showed that 15 batches of samples were divided into 2 classes, of which S1-S5, S7 and S9 were one class and the rest were one class, similar to the results of principal component analysis. The results of the orthogonal partial least squares-discriminant analysis showed that the variable importance projections of peaks No. 2, 6, 1, 11 (quercetin), 3, 14, 8, 10, 19 (emodin), 5 were all greater than 1. The contents of quercetin, kaempferol, kaempferide and emodin ranged from 0.710 to 10.478 mg/g, 0.236 to 0.660 mg/g, 0.334 to 3.039 mg/g, and 0.261 to 0.504 mg/g.CONCLUSIONSThe constructed chemical constituent identification, fingerprint and content determination methods are simple, feasible and reproducible, which combined with chemometric analysis can be used for comprehensive evaluation of the quality of Rhamni Songoricae Fructus.
摘要:OBJECTIVETo study the effects of leonurine on pancreatic injury in rats with severe acute pancreatitis (SAP), and to explore its mechanism based on the high-mobility group box 1 (HMGB1)/receptor for advanced glycation end products (RAGE) signaling pathway.METHODSSAP rat model was constructed by injecting 5% sodium taurocholate into the bile duct of the pancreas. Model rats were randomly divided into model group, low dose leonurine group (8 mg/kg), high dose leonurine group (16 mg/kg), HMGB1 overexpression group (8 μg/kg), and high dose leonurine+HMGB1 overexpression group (16 mg/kg+8 μg/kg), with 14 rats in each group. Another 14 rats were selected as the sham operation group. Rats in each group were injected with corresponding drugs or normal saline via abdominal cavity or tail vein once a day for 5 consecutive days. After the last administration, the levels of serum amylase (AMS) and lipase (LPS) were detected; the pathological injury of pancreatic tissue was observed; the levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), malondialdehyde (MDA) and superoxide dismutase (SOD), mRNA and protein expressions of HMGB1 and RAGE in pancreatic tissues were detected.RESULTSCompared with model group, the structure of pancreatic tissue in rats gradually recovered in low and high dose leonurine groups; inflammatory cell infiltration gradually decreased; the pathological injury score and the levels of AMS, LPS, TNF-α, IL-6, MDA, the mRNA and protein expressions of HMGB1 and RAGE were significantly decreased, while the SOD levels were significantly increased (P<0.05). The high dose leonurine group showed more significant improvement (P<0.05); the pathological damage of pancreatic tissue in the HMGB1 overexpression group worsened, and except for a decrease in SOD levels, all other quantitative indicators increased significantly (P<0.05). Overexpression of HMGB1 could reduce the improvement effect of high dose leonurine on the above indexes in SAP rats (P<0.05).CONCLUSIONSLeonurine may alleviate pancreatic injury, inflammation and oxidative stress in pancreatic tissue of rats with SAP by inhibiting the HMGB1/RAGE signaling pathway.
摘要:OBJECTIVETo establish characteristic chromatogram of Yao medicine Kadsura longipedunculata and the method for the content determination of its main component anwulignan, and evaluate the anti-inflammatory activity of anwulignan.METHODSHPLC method was performed with acetonitrile-0.5% phosphoric acid solution as the mobile phase for gradient elution. The characteristic chromatogram of K. longipedunculata was established and similarity was evaluated by Similarity Evaluation System for Chromatographic Fingerprint of TCM (2012 edition). The content of anwulignan in K. longipedunculata was determined. Lipopolysaccharide induced RAW264.7 macrophages were selected as inflammatory cell model to investigate the effects of anwulignan on the levels of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and IL-6.RESULTSThe similarities of characteristic chromatogram for 10 batches of K. longipedunculata ranged 0.901-0.994, and 9 common peaks were determined; 3 components were identified, such as changnan schisantherin E, kadsulactone A, anwulignan. The contents of anwulignan were (0.72±0.05)-(1.21±0.03) mg/g(n=3). Anwulignan of 0.125-0.5 μg/mL greatly decreased the levels of TNF-α, IL-1β and IL-6 in the supernatant of inflammatory model cells (P<0.05 or P<0.01).CONCLUSIONSHPLC characteristic chromatogram of K. longipedunculata and the method for the content determination of anwulignan are all established, and anwulignan may be the active ingredient of anti-inflammatory effect in K. longipedunculata.
摘要:OBJECTIVETo investigate the effects of 0.2% chloroprocaine combined with ropivacaine on epidural labor analgesia and median effective concentration (EC50) of ropivacaine.METHODSTotally 67 parturients who scheduled for vaginal delivery and required epidural labor analgesia were collected from our hospital from July to October 2023 and randomly divided into RL group (33 cases) and R group (34 cases). The concentration of ropivacaine was determined by modified Dixon sequential method. RL group was given 0.2% Chloroprocaine hydrochloride injection+Ropivacaine hydrochloride injection+0.4 μg/mL Sufentanil citrate injection; R group was given Ropivacaine hydrochloride injection+0.4 μg/mL Sufentanil citrate injection. EC50 of ropivacaine, analgesic effect during delivery, total dosage of analgesic drugs, analgesic satisfaction score, the incidence of adverse reactions, delivery status, and Apgar score of newborns were observed in two groups.RESULTSEC50 of ropivacaine, onset time, remedial analgesia rate, the incidence of perineal distension and breakthrough pain and total dosage of analgesic drugs of RL group were significantly lower than R group, and analgesic satisfaction score was significantly higher than R group (P<0.05). There was no statistical significance in the incidence of adverse reactions such as numbness, weakness, and chills in the lower limbs, or the duration of labor, amount of bleeding, mode of delivery, and Apgar score of newborns between 2 groups (P>0.05).CONCLUSIONSFor epidural labor analgesia, 0.2% chloroprocaine combined with ropivacaine can reduce EC50 of ropivacaine, improve analgesia effect and have good safety.
摘要:OBJECTIVETo observe the effects of liraglutide on cardiovascular metabolism, left ventricular structure and function of non-alcoholic fatty liver disease (NAFLD) patients with type 2 diabetes mellitus (T2DM).METHODSTotally 351 NAFLD patients with T2DM were enrolled retrospectively, who visited the Department of Endocrinology in our hospital from January 2019 to December 2022. They were divided into control group (196 cases) and observation group (155 cases) according to different treatment regimens. The control group received conventional standard treatment, and the observation group was additionally given Liraglutide injection 0.6 mg/d subcutaneously once a day based on the control group, adjusted to 1.2 mg/d after 7 days. Both groups received regular treatment for more than 12 months. The propensity matching method was used to match the two groups of patients at a ratio of 1∶1. The cardiovascular metabolism indexes and cardiac ultrasound parameters were compared, and the correlation between left ventricular structure, function parameters and cardiovascular metabolism indexes was analyzed.RESULTSAfter propensity score matching, there was no significant difference in baseline clinical data between the two groups (each 155 cases) before treatment (P>0.05). After 12 months of treatment, the waist circumference, weight, body mass index (BMI), systolic blood pressure (SBP), fasting blood glucose (FBG), glycosylated hemoglobin (HbA1c) and triglyceride (TG) of both groups, as well as the diastolic blood pressure (DBP), total cholesterol (TC), uric acid (UA) and left ventricular mass (LVM) of the observation group, exhibited a significant decrease compared to pre-treatment levels (P<0.05). The high-density lipoprotein cholesterol (HDL-C), estimated glomerular filtration rate (eGFR), and E/A ratio in both groups, as well as the aspartate aminotransferase (AST) in the control group and the left ventricular ejection fraction (LVEF) in the observation group, were all significantly increased compared with before treatment in the same group (P<0.05). Moreover, the improvement of the above indicators (except for TG and SBP) in the observation group was generally more significant than those in the control group (P<0.05). The left ventricular structure and functional parameters (LVM, LVEF, E/A ratio) of the two groups before and after treatment had varying degrees of correlation with the patients’ waist circumference, body weight, BMI, SBP, FBG and HbA1c. Moreover, BMI (observation group: β=0.229, P=0.004) and SBP (control group: β=0.240, P=0.004; observation group: β=0.226, P=0.007) were independent influential factors for LVM of the patients.CONCLUSIONSLiraglutide combined with conventional standard treatment can effectively control blood glucose in NAFLD patients with T2DM, reduce waist circumference, body weight and blood pressure, improve blood lipid disorders, and protect their cardiac structure and function.
摘要:OBJECTIVETo observe the short-term efficacy and safety of venetoclax combined with homoharringtonine and cytarabine in the treatment of acute myeloid leukemia (AML).METHODSThe data of 40 newly diagnosed AML patients admitted to our hospital from October 2022 to November 2023 were retrospectively collected and divided into observation group and control group according to treatment plan, with 20 cases in each group. The patients in the control group were given Daunorubicin hydrochloride for injection+Cytarabine for injection, and the patients in the observation group were given Venetoclax tablets+Homoharringtonine injection+Cytarabine for injection. The patients in both groups were given relevant medicine, with 28 days as one cycle. The short-term efficacy, negative rate of minimal residual disease (MRD), duration of granulocyte deficiency, duration of platelet (PLT) <20×109 L-1, transfusion volume of suspended red blood cells and platelet, and the occurrence of adverse drug reactions were evaluated in both groups after 1 cycle of induction chemotherapy.RESULTSThe complete remission or complete remission with incomplete hematologic recovery (CR/CRi) rate in the observation group was significantly higher than control group (P<0.05), and the negative rate of MRD in the observation group was also significantly higher than control group (P<0.05). However, in low-, medium- and high-risk patients, there was no statistical significance in CR/CRi rates between the two groups (P>0.05). There were no significant differences in the duration of agranulocytosis, the duration of PLT <20×109 L-1, the amount of suspended red blood cell transfusion, the amount of platelet transfusion, the incidence of hematologic toxicity and the incidence of non-hematologic toxicity between 2 groups (P>0.05).CONCLUSIONSVenetoclax combined with homoharringtonine and cytarabine show good short-term efficacy and safety in the treatment of AML.
摘要:OBJECTIVETo observe the efficacy and safety of goserelin combined with estradiol valerate in the treatment of endometriosis (EMs) in patients of childbearing age after laparoscopic surgery.METHODSThe clinical data of 144 patients with EMs of childbearing age who underwent laparoscopic surgery in our hospital from January 2020 to December 2022 were collected retrospectively, and those patients were divided into control group (70 cases) and combination group (74 cases) based on different postoperative medication regimens. Control group was given Acetate goserelin sustained-release implant on the 1st to 5th day of their first menstrual cycle after laparoscopic surgery, while combination group was additionally given Estradiol valerate tablets on the basis of control group. The short-term and long-term efficacy of 2 groups were observed; preoperative and postoperative pain scores, ovarian reserve function, and the incidence of adverse reactions were all recorded in 2 groups.RESULTSThere was no statistically significant difference in short-term total effective rate, 1-year postoperative recurrence rate and the incidence of decreased libido, vaginal dryness, gastrointestinal reactions, rash, or arrhythmia between two groups (P>0.05). The natural pregnancy rate of combination group was significantly higher than control group at 1 year after surgery, while the incidence of early miscarriage, hot flashes and sweating, emotional fluctuations, insomnia and fatigue, joint muscle pain, dizziness and headache were significantly lower than control group (P<0.05). However, at 6 months after surgery, pain scores and the levels of anti-Müllerian hormone, follicle stimulating hormone, luteinizing hormone, estradiol of both groups were significantly lower than before surgery in the same group, while the number of antral follicle count was significantly higher than before surgery in the same group; the levels of anti-Müllerian hormone, luteinizing hormone, estradiol, and the number of antral follicles in the combination group were significantly higher than control group, while pain score and follicle stimulating hormone level were significantly lower than control group (P<0.05).CONCLUSIONSThe combination of goserelin and estradiol valerate after laparoscopic surgery has a significant therapeutic effect and good safety in the treatment of EMs of childbearing age.
摘要:OBJECTIVETo investigate the efficacy and safety of piperacillin-tazobactam in the treatment of complicated urinary tract infection (cUTI) in adults.METHODSRetrospective analysis was performed on the data of 352 cUTI adult patients in our hospital from January 1, 2021 to December 31, 2023. All patients received piperacillin-tazobactam. The detection of pathogens in patients, the clinical efficacy and microbial clearance rate after treatment, the occurrence of adverse drug reactions and treatment cost were observed in all patients.RESULTSOf the 352 patients, pathogen culture results of 54 patients were detected, mainly Escherichia coli producing extended-spectrum beta-lactamases. The clinical effective rate was 94.3%, the microbial clearance rate was 81.5%, and the incidence of adverse reactions was 1.4%. The percentage of male effective patients in urinary surgery department was significantly higher than invalid patients, while the proportion of transplant treatment and the proportion of patients with concomitant kidney transplantation were significantly lower than invalid patients (P<0.05). There was no significant difference in clinical effective rate between the two groups after those patients were divided into target treatment group and empirical treatment group according to the sensitivity of pathogen to piperacillin-tazobactam (P=0.902 5).CONCLUSIONSPiperacillin-tazobactam is effective and safe in the treatment of cUTI.
摘要:OBJECTIVETo analyze the distribution characteristics of warfarin drug-gene polymorphism in Han children from Beijing area.METHODSData of nine warfarin drug-gene loci about VKORC1 rs9923231, CYP2C9 rs1799853*2 and rs1057910*3, CYP4F2 rs2108622, APOE rs429358 and rs7412, ABCB1 rs1045642, EPHX1 rs1051740 and rs2234922 were collected from dept. of cardiovascular medicine, Children’s Hospital Affiliated to Capital Institute of Pediatrics from March 2019 to March 2023, and the population data reported in domestic and foreign literature were compared.RESULTSIn Beijing area, the frequency of APOE rs429358 mutant genotype was higher in males (19.8%) than in females (13.5%)(P<0.05). VKORC1 rs9923231 was dominated by homozygous mutant genotype (83.3%), which was consistent with children in Japan (82.2%), and higher than that of predominantly Caucasian children in the UK, Sweden, the United States, and Germany (10.4%-18.3%)(P<0.05); CYP2C9 was dominated by *1/*1 type (91.9%), which was consistent with children in Japan (94.6%), and higher than that of predominantly Caucasian children in the UK, Sweden, the United States, and Germany (66.1%-73.4%)(P<0.05). The frequency of EPHX1 rs1051740 mutant genotype was higher in adults (78.5%) than in children (63.5%)(P<0.05).CONCLUSIONSMore mutations of VKORC1 rs9923231 and ABCB1 rs1045642 are found in Han children from Beijing area. The distribution of warfarin drug-gene polymorphisms in Han children from Beijing area is different among different genders, as well as compared with other countries, and Chinese Han adults. Therefore, caution should be exercised when using the reported data.
摘要:OBJECTIVETo investigate the effects of CYP3A5 gene polymorphism and Wuzhi capsule (WZ) on early postoperative tacrolimus exposure and adverse reactions in renal transplant patients.METHODSA total of 132 patients who underwent renal transplantation and received tacrolimus + mycophenolic acids + prednisone after operation in our hospital from September 2021 to September 2023 were selected and divided into four groups according to genotypes (CYP3A5*1 or CYP3A5*3/*3) and with or without WZ (“+WZ” meant drug combination, “+NO WZ” meant without combination). The blood trough concentration/daily dose (c0/D) values of the four groups were analyzed on the 14th day, 1 month and 3 months after renal transplantation. The incidence of acute rejection and the incidence of tacrolimus-related adverse reactions within 3 months after transplantation were compared among 4 groups.RESULTSOn the 14th day, 1 month and 3 months after surgery (except for the CYP3A5*1+WZ group), c0/D values of CYP3A5*1 genotype patients were significantly lower than those of CYP3A5*3/*3 genotype patients regardless of whether they were treated with WZ additionally (P<0.05). Within 3 months after surgery, although there was no significant difference in the incidence of acute rejection and tacrolimus-related adverse reactions among the four groups (P>0.05), the incidence of hyperglycemia in patients with CYP3A5*3/*3 was higher (41.67%).CONCLUSIONSCYP3A5 gene polymorphism is significantly related to tacrolimus c0/D in kidney transplant patients. Under the premise of c0 monitoring of tacrolimus, patients with CYP3A5*1 genotype should be given WZ as soon as possible after surgery to accelerate tacrolimus to reach the therapeutic concentration range, while CYP3A5*3/*3 genotype is not recommended to be given WZ because of the higher risk of hyperglycemia.
摘要:OBJECTIVETo investigate the effects of sacubitril/valsartan on renal function in patients with primary hypertension.METHODSA retrospective study was conducted among patients with primary hypertension who were admitted to PLA Strategic Support Force Characteristic Medical Center from January 2018 to June 2023. Based on their medication, they were divided into two groups: sacubitril/valsartan group and valsartan group. Propensity score matching was used to match baseline data between the two groups. Patients were treated with antihypertensive drugs based on improving their lifestyle. Sacubitril/valsartan group additionally received oral administration of 200 mg Sacubitril/valsartan tablets once daily, while valsartan group additionally received oral administration of 80 mg Valsartan capsules once daily. The increase amplitude of serum creatinine from baseline, the proportion of patients with elevated serum creatinine >30%-50% or >50%, and the proportion of patients with hyperkalemia (serum potassium ≥5.5 mmol/L) were compared between two groups at 2 months and 6 months after treatment. The trends of changes in serum creatinine, serum potassium and estimated glomerular filtration rate (eGFR) were compared between the two groups before treatment (at baseline), 2 months and 6 months after treatment.RESULTSAfter propensity score matching, there were 62 patients in sacubitril/valsartan group and 61 patients in valsartan group; there were no significant differences in baseline characteristics between the two groups before treatment (P>0.05), indicating comparability. After 6 months of treatment, the increase of serum creatinine in the sacubitril/valsartan group was significantly lower than that in the valsartan group (P=0.003); the proportion of patients with elevated serum creatinine >30%-50% in the sacubitril/valsartan group was significantly lower than that in the valsartan group (P=0.045). None of the patients experienced hyperkalemia events after 2 months and 6 months of treatment. Repeated measures analysis of variance showed significantly statistical differences in serum creatinine and eGFR between the two groups within 6 months of treatment (P<0.001). Patients taking valsartan experienced a continuous increase in serum creatinine levels and a decrease in eGFR, while patients taking sacubitril/valsartan showed a first increase and then a decrease in serum creatinine levels, and a first decrease and then an increase in eGFR with a prolonged duration of medication.CONCLUSIONSSacubitril/valsartan can delay or even reverse the decline in renal function levels, and limit the deterioration of renal function in patients with primary hypertension, without increasing the risk of hyperkalemia.
摘要:OBJECTIVETo evaluate the efficacy and safety of dimethyl fumarate (DMF) in the treatment of multiple sclerosis (MS).METHODSRetrieved from CBM, Web of Science, PubMed, the Cochrane Library, Embase, CNKI, Wanfang Data, and VIP, randomized controlled trials (RCTs) about DMF (trial group) versus other drugs or placebo (control group) were collected. After data screening and extraction, quality evaluation, meta-analysis was conducted by using RevMan 5.3 software.RESULTSA total of 6 literature were included, involving 638 patients. Results of meta-analysis showed that the proportion of patients with lesion changes after treatment in the trial group was lower than control group [MD=-0.65, 95%CI(-1.27, -0.02), P=0.04]; there was no statistical significance in recurrence rate [RR=1.06, 95%CI(0.52,2.17), P=0.88], the proportion of patients with new lesions after treatment [RR=1.05, 95%CI(0.62,1.80), P=0.85], expanded disability status scale after treatment [MD=0.02,95%CI (-0.18, 0.23), P=0.82], the incidence of adverse events [RR=1.33, 95%CI(0.97, 1.84), P=0.08] or severe adverse events [RR=0.95,95%CI(0.48,1.90),P=0.89] between 2 groups. Results of sensitivity analysis showed the study obtained unstable recurrence rate and the incidence of adverse events, while other results were robust.CONCLUSIONSDMF can control the lesion progression in MS patients to some extent and doesn’t increase the incidence of adverse events and serious adverse events, but there is no significant advantage in reducing the recurrence rate and controlling the disability progression.
摘要:OBJECTIVETo compare the general status of training programs for geriatric clinical pharmacists in China and the United States, and provide a reference for further optimizing training programs of geriatric clinical pharmacists in China.METHODSRetrieved from the American Society of Health-System Pharmacists (ASHP) website and the Chinese Hospital Association website, the detailed information and data on training outline, institution type/scale, enrollment number, training contents, project application conditions and graduation assessments for clinical pharmacists in geriatric field were collected and statistical analysis was performed using Excel software. RESULTS &CONCLUSIONSAs of January 12, 2024, ASHP provided 24 geriatric clinical pharmacist training programs and 25 positions available for application in the postgraduate year two training, which provided compensation. The training base involved hospitals and pharmaceutical colleges, with varying scales. Applicants needed to obtain a doctor of pharmacy and complete postgraduate year one training. ASHP had designed detailed training objectives for the four essential skills of basic patient care, advanced patient care, leadership and management skills, and knowledge education and teaching dissemination. Each training base could appropriately add optional skills such as academic skills, long-term care skills and other skills according to its characteristics, developed a student rotation plan, and conducted assessments and evaluations at multiple time points during the training process. There were 5 training programs for geriatric clinical pharmacists in China, with 15 positions, which didn’t provide compensation; training bases were all third-grade class A hospitals with relatively large scale. The applicant needed to obtain a bachelor’s degree or above, and different years of work were required based on their major and degree level. The Pharmaceutical Specialized Committee of the China Hospital Association had established a detailed training outline, proposing specific training objectives on theoretical knowledge, practical skills, scientific research thinking, etc. The training base organized assessments and evaluations at the time of enrollment, completion of specified content training, and graduation. According to the experience of the US, it is recommended to provide differentiated knowledge and skills training for students at different levels, flexibly arrange rotating departments, require students to work independently and deeply participate in clinical teaching and research work, conduct multiple and various forms of assessments, and adjust learning plans in a timely manner to comprehensively enhance their abilities.
摘要:OBJECTIVETo standardize the use of sterile powder for injection redissolution solvent and intravenous drugs diluent solvent, and ensure the safety of clinical drug use.METHODSThe intravenous drug resolvent generation system and the intravenous drug solvent incompatibility rules library were constructed and operated by prescription-checking pharmacist team in our hospital by formulating a list of intravenous drugs needed to be dissolved with sterilized water for injection and a contraindication list of intravenous solvent compatibility. The unreasonable medical orders reviewed and intervened in our hospital from January to April 2023 (before the implementation of the intravenous drug solvent incompatibility rules library) and from May to August 2023 (after the implementation) were analyzed statistically to compare the number of unreasonable solvent selection orders, interception rate, and the success rate of pharmacists’ interventions for unreasonable solvent selection orders before and after the implementation.RESULTSBefore the implementation of the solvent incompatibility rules library, a total of 5 229 groups of medical orders with unreasonable solvent selection in our hospital were identified, among which there were 1 204 groups of seriously unreasonable medical orders, with interception rate of 23.03% and the success rate of pharmacists’ intervention of 15.90%. After the implementation of the solvent incompatibility rules library, the total number of medical orders with unreasonable solvent selection was 3 258 groups, among which there were 1 148 groups of seriously unreasonable medical orders, with interception rate of 35.24% and success rate of pharmacists’ intervention of 24.83%, being significantly higher than before implementation (P<0.01 or P<0.001).CONCLUSIONSThe establishment and application of the intravenous drug resolvent generation system and the solvent incompatibility rules library can significantly increase the interception rate of unreasonable solvent selection orders and the success rate of pharmacists’ interventions, and ensure the safety of clinical drug use.
摘要:odium-glucose linked transporter 2 inhibitors(SGLT2i) are novel oral hypoglycaemic agents and are widely used for hypoglycemic therapy in patients with type 2 diabetes mellitus, but differences in the genetic backgrounds of patients often lead to variable responsiveness to drug therapy. By summarizing the pharmacogenomic studies of SGLT2i, the article found that the genetic variants of UGT1A9, UGT2B4, SLC5A2, ABCB1, PNPLA3 and WFS1 may influence the pharmacokinetics of SGLT2i and the external hypoglycemic effects of SGLT2i in improving non-alcoholic fatty liver disease, weight loss and so on, but there is no clinical evidence that genetic polymorphisms affect the hypoglycemic efficacy of SGLT2i.
摘要:Renal interstitial fibrosis(RIF) is the main pathological manifestation of chronic kidney disease. Due to the complexity of the mechanism, there is no specific treatment for RIF in clinical practice. The abnormal activation of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B(Akt) signaling pathway and the activation of downstream target genes are key drivers of RIF induction and progression. Traditional Chinese medicine has the characteristics of precise efficacy and minimal toxic side effects, and the occurrence and development of RIF can be regulated by multiple targets and mutual coordination. This review focuses on the PI3K/Akt signaling pathway and summarizes the potential targets and regulatory mechanisms of traditional Chinese medicine in the treatment of RIF. It is found that various effective ingredients (such as sinomenine, mangiferin, coumarin derivates from Hydrangea paniculata, etc.) and formulas (such as Fushengong decoction, Qi-Bang-Yi-Shen formula, etc.) of traditional Chinese medicine can inhibit fibroblast proliferation, improve inflammation and oxidative stress, maintain mitochondrial stability, and slow down ferroptosis through this pathway, thereby delaying the occurrence and progression of RIF.
关键词:PI3K/Akt signaling pathway;renal interstitial fibrosis;action of mechanism